Your browser doesn't support javascript.
loading
Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer.
Carvalho, Robson Francisco; do Canto, Luisa Matos; Cury, Sarah Santiloni; Frøstrup Hansen, Torben; Jensen, Lars Henrik; Rogatto, Silvia Regina.
Afiliación
  • Carvalho RF; Department of Clinical Genetics, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
  • do Canto LM; Institute of Regional Health Research, University of Southern Denmark, 5230 Odense, Denmark.
  • Cury SS; Department of Functional and Structural Biology-Institute of Bioscience, São Paulo State University (UNESP), Botucatu 18618-689, Brazil.
  • Frøstrup Hansen T; Department of Clinical Genetics, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
  • Jensen LH; Institute of Regional Health Research, University of Southern Denmark, 5230 Odense, Denmark.
  • Rogatto SR; Department of Functional and Structural Biology-Institute of Bioscience, São Paulo State University (UNESP), Botucatu 18618-689, Brazil.
Cancers (Basel) ; 13(21)2021 Oct 31.
Article en En | MEDLINE | ID: mdl-34771654
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Suiza